KBC Group’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78K | Sell |
3,619
-1,474
| -29% | -$31.8K | ﹤0.01% | 1360 |
|
|
2025
Q1 | $85K | Hold |
5,093
| – | – | ﹤0.01% | 1574 |
|
|
2024
Q4 | $93K | Buy |
5,093
+2,044
| +67% | +$37.3K | ﹤0.01% | 1602 |
|
|
2024
Q3 | $47K | Hold |
3,049
| – | – | ﹤0.01% | 1733 |
|
|
2024
Q2 | $50K | Buy |
+3,049
| New | +$50K | ﹤0.01% | 1609 |
|
|
2024
Q1 | – | Sell |
-2,659
| Closed | -$83K | – | 1845 |
|
|
2023
Q4 | $83K | Hold |
2,659
| – | – | ﹤0.01% | 1162 |
|
|
2023
Q3 | $55K | Buy |
+2,659
| New | +$55K | ﹤0.01% | 1364 |
|